These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30891118)

  • 1. Allosteric Modulation of Ionotropic Glutamate Receptors: An Outlook on New Therapeutic Approaches To Treat Central Nervous System Disorders.
    Brogi S; Campiani G; Brindisi M; Butini S
    ACS Med Chem Lett; 2019 Mar; 10(3):228-236. PubMed ID: 30891118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deeper Insights into the Allosteric Modulation of Ionotropic Glutamate Receptors.
    Regan MC; Furukawa H
    Neuron; 2016 Sep; 91(6):1187-1189. PubMed ID: 27657445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of metabotropic glutamate receptor allosteric modulators: structural basis and therapeutic potential for CNS disorders.
    Gregory KJ; Noetzel MJ; Niswender CM
    Prog Mol Biol Transl Sci; 2013; 115():61-121. PubMed ID: 23415092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supraspinal metabotropic glutamate receptors: a target for pain relief and beyond.
    Palazzo E; Marabese I; de Novellis V; Rossi F; Maione S
    Eur J Neurosci; 2014 Feb; 39(3):444-54. PubMed ID: 24494684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron Emission Tomography (PET) Ligand Development for Ionotropic Glutamate Receptors: Challenges and Opportunities for Radiotracer Targeting N-Methyl-d-aspartate (NMDA), α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA), and Kainate Receptors.
    Fu H; Chen Z; Josephson L; Li Z; Liang SH
    J Med Chem; 2019 Jan; 62(2):403-419. PubMed ID: 30110164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ionotropic and metabotropic glutamate receptor structure and pharmacology.
    Kew JN; Kemp JA
    Psychopharmacology (Berl); 2005 Apr; 179(1):4-29. PubMed ID: 15731895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential.
    Kew JN
    Pharmacol Ther; 2004 Dec; 104(3):233-44. PubMed ID: 15556676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-Based Approaches for Allosteric Metabotropic Glutamate Receptor (mGluR) Modulators.
    Orgován Z; Ferenczy GG; Keserű GM
    Curr Top Med Chem; 2019; 19(19):1768-1781. PubMed ID: 31393248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from more than 80 structures of the GluA2 ligand-binding domain in complex with agonists, antagonists and allosteric modulators.
    Pøhlsgaard J; Frydenvang K; Madsen U; Kastrup JS
    Neuropharmacology; 2011 Jan; 60(1):135-50. PubMed ID: 20713069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Potential Dual Negative Allosteric Modulators of Group I mGluR Family: A Shape Based Screening, ADME Prediction, Induced Fit Docking and Molecular Dynamics Approach Against Neurodegenerative Diseases.
    Prabhu SV; Singh SK
    Curr Top Med Chem; 2019; 19(29):2687-2707. PubMed ID: 31702505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropharmacological Insight from Allosteric Modulation of mGlu Receptors.
    Stansley BJ; Conn PJ
    Trends Pharmacol Sci; 2019 Apr; 40(4):240-252. PubMed ID: 30824180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for evaluation of positive allosteric modulators of glutamate AMPA receptors.
    Siuda ER; Quirk JC; Nisenbaum ES
    Methods Mol Biol; 2007; 403():37-57. PubMed ID: 18827986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New therapeutic frontiers for metabotropic glutamate receptors.
    Niswender CM; Jones CK; Conn PJ
    Curr Top Med Chem; 2005; 5(9):847-57. PubMed ID: 16178730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mGluR5 negative allosteric modulators overview: a medicinal chemistry approach towards a series of novel therapeutic agents.
    Rocher JP; Bonnet B; Boléa C; Lütjens R; Le Poul E; Poli S; Epping-Jordan M; Bessis AS; Ludwig B; Mutel V
    Curr Top Med Chem; 2011; 11(6):680-95. PubMed ID: 21261592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabotropic glutamate receptors as drug targets.
    Récasens M; Guiramand J; Aimar R; Abdulkarim A; Barbanel G
    Curr Drug Targets; 2007 May; 8(5):651-81. PubMed ID: 17504108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biased agonism and allosteric modulation of metabotropic glutamate receptor 5.
    Trinh PNH; May LT; Leach K; Gregory KJ
    Clin Sci (Lond); 2018 Nov; 132(21):2323-2338. PubMed ID: 30389826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate receptors in the mammalian central nervous system.
    Ozawa S; Kamiya H; Tsuzuki K
    Prog Neurobiol; 1998 Apr; 54(5):581-618. PubMed ID: 9550192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure, Dynamics, and Allosteric Potential of Ionotropic Glutamate Receptor N-Terminal Domains.
    Krieger J; Bahar I; Greger IH
    Biophys J; 2015 Sep; 109(6):1136-48. PubMed ID: 26255587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation.
    Gregory KJ; Conn PJ
    Mol Pharmacol; 2015 Jul; 88(1):188-202. PubMed ID: 25808929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders.
    Foster DJ; Conn PJ
    Neuron; 2017 May; 94(3):431-446. PubMed ID: 28472649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.